Ngo Minh Toan

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2022-2025

2025

Ngo, M. T., Nagy, T., Szoboszlai, Z., Csikos, C., Dénes, N., Furka, A., Trencsényi, G., Garai, I.: The Relationship of Metabolic Activity and αvβ3 Receptor Expression in Aggressive Breast Cancer Subtypes Tumors: a Preliminary Report.
In Vivo. 39 (1), 160-171, 2025.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2024)

Q3 Cancer Research (2024)

Q2 Medicine (miscellaneous) (2024)

Q3 Pharmacology (2024)

2024

Ngo, M. T.: Novel Molecular Classification of Breast Cancer with PET Imaging.
Medicina (Kaunas). 60 (12), 1-35, (article identifier: 2099), 2024.

doi DEA WoS

Journal metrics:

Q2 Medicine (miscellaneous)

Ngo, M. T., Lê, Á. N., Đinh, D. P. H.: The Impact of Chemotherapy on Cardiovascular Mortality across Breast Cancer Subtypes.
Current Oncology. 31 (2), 649-659, 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Oncology

2023

Csikos, C., Vágner, A., Nagy, G., Kálmán-Szabó, I., Péli-Szabó, J., Ngo, M. T., Szoboszlai, Z., Szikra, D. P., Krasznai, Z. T., Trencsényi, G., Garai, I.: In Vivo Preclinical Assessment of the VEGF Targeting Potential of the Newly Synthesized [52Mn]Mn-DOTAGA-Bevacizumab Using Experimental Cervix Carcinoma Mouse Model.
Diagnostics. 13 (2), 236-, 2023.

doi DEA WoS Scopus

Journal metrics:

Q2 Clinical Biochemistry

2022

Vágner, A., Ngo, M. T., Nagy, G., Nagy, T., Sajtos, G. Z., Váradi, B., Szikra, D. P., Tircsó, G., Garai, I.: In vivo imaging of HER2 receptor status with a novel Mn-52-labelled antibody.
Eur. J. Nucl. Med. Mol. Imaging. 49 (SUPPL1), S282-S282, 2022.

DEA WoS

Váradi, B., Garda, Z., Madarasi, E., Brezovcsik, K., Vágner, A., Nagy, T., Garai, I., Ngo, M. T., Puiu, A. G., Vasilescu, A. M., Szűcs, Z., Szedlacsek, S. E., Nagy, G., Tircsó, G.: Labelling anti-HER2-affibodies with Mn-52 via pyclen based bifunctional ligands: from ligand design to in vivo PET/MR experiments.
Eur. J. Nucl. Med. Mol. Imaging. 49 (SUPPL1), S283-S283, 2022.

DEA WoS